Cetuximab therapy was started on the day radiation therapy began with a loading dose of 400 mg/m 2 in the first week, and then 250 mg/m 2 /week for the successive radiation weeks. One cycle of ...

Cetuximab is a monoclonal antibody with activity against colorectal cancers that overexpress epidermal growth factor receptor. This agent blocks epidermal growth factor receptor signaling and ...

Johnson & Johnson (NYSE:JNJ) has announced that the U.S. FDA has declined to approve an injectable version of its cancer ...

Indeed, results from the FLEX trial demonstrate that cetuximab in combination with platinum-based chemotherapy is a new treatment strategy for patients with advanced NSCLC. The EGFR pathway has an ...

The application includes an every-three-week (Q3W) amivantamab regimen in combination with carboplatin and pemetrexed. This would be for adult patients with advanced non-small cell lung cancer (NSCLC) ...

CRYSTAL: Cetuximab Combined with Irinotecan in First Line Therapy for Metastatic Colorectal Cancer; HR: Hazard ratio; FOLFIRI: Folinic acid and fluorouracil-based regimen containing irinotecan ...